These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10551518)

  • 1. GISSI-Prevenzione trial.
    Jialal I; Devaraj S; Huet BA; Traber M
    Lancet; 1999 Oct; 354(9189):1554; author reply 1556-7. PubMed ID: 10551518
    [No Abstract]   [Full Text] [Related]  

  • 2. GISSI-Prevenzione trial.
    Ng W; Tse HF; Lau CP
    Lancet; 1999 Oct; 354(9189):1555-6; author reply 1556-7. PubMed ID: 10551521
    [No Abstract]   [Full Text] [Related]  

  • 3. GISSI-Prevenzione trial.
    Hopper L; Ness A; Higgins JP; Moore T; Ebrahim S
    Lancet; 1999 Oct; 354(9189):1557. PubMed ID: 10551523
    [No Abstract]   [Full Text] [Related]  

  • 4. Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the GISSI-Prevenzione trial.
    Marchioli R; Marfisi RM; Borrelli G; Chieffo C; Franzosi MG; Levantesi G; Maggioni AP; Nicolosi GL; Scarano M; Silletta MG; Schweiger C; Tavazzi L; Tognoni G
    J Cardiovasc Med (Hagerstown); 2007 Sep; 8 Suppl 1():S34-7. PubMed ID: 17876196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The results of the GISSI-Prevenzione trial in the general framework of secondary prevention.
    Marchioli R; Valagussa F
    Eur Heart J; 2000 Jun; 21(12):949-52. PubMed ID: 10901501
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of GISSI Prevenzione: diet, drugs, and cardiovascular risk. Researchers of GISSI Prevenzione].
    Marchioli R
    Cardiologia; 1999 Dec; 44 Suppl 1(Pt 2):745-6. PubMed ID: 12503535
    [No Abstract]   [Full Text] [Related]  

  • 7. GISSI-Prevenzione trial.
    Salen P; de Lorgeril M
    Lancet; 1999 Oct; 354(9189):1555; author reply 1556-7. PubMed ID: 10551520
    [No Abstract]   [Full Text] [Related]  

  • 8. [The biochemical, pharmacological and epidemiological reference picture of the GISSI-Prevention. The Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico].
    Marchioli R; Di Pasquale A
    G Ital Cardiol; 1993 Sep; 23(9):933-64. PubMed ID: 8119523
    [No Abstract]   [Full Text] [Related]  

  • 9. Vitamin E increases the risk of developing heart failure after myocardial infarction: Results from the GISSI-Prevenzione trial.
    Marchioli R; Levantesi G; Macchia A; Marfisi RM; Nicolosi GL; Tavazzi L; Tognoni G; Valagussa F;
    J Cardiovasc Med (Hagerstown); 2006 May; 7(5):347-50. PubMed ID: 16645413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GISSI-Prevenzione trial.
    Harrison R; Burr M; Elton P
    Lancet; 1999 Oct; 354(9189):1554-5; author reply 1556-7. PubMed ID: 10551519
    [No Abstract]   [Full Text] [Related]  

  • 11. Highly purified omega-3 polyunsaturated fatty acids are effective as adjunct therapy for secondary prevention of myocardial infarction.
    Verboom CN;
    Herz; 2006 Dec; 31 Suppl 3():49-59. PubMed ID: 17575805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.
    Lancet; 1999 Aug; 354(9177):447-55. PubMed ID: 10465168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial.
    Marchioli R; Levantesi G; Macchia A; Maggioni AP; Marfisi RM; Silletta MG; Tavazzi L; Tognoni G; Valagussa F;
    J Membr Biol; 2005 Jul; 206(2):117-28. PubMed ID: 16456722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial.
    Franzosi MG; Brunetti M; Marchioli R; Marfisi RM; Tognoni G; Valagussa F;
    Pharmacoeconomics; 2001; 19(4):411-20. PubMed ID: 11383757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multi-country health-economic evaluation of highly concentrated n-3 polyunsaturated fatty acids in the secondary prevention after myocardial infarction.
    Lamotte M; Annemans L; Kawalec P; Zoellners Y
    Herz; 2006 Dec; 31 Suppl 3():74-82. PubMed ID: 17575809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A multi-country health economic evaluation of highly concentrated N-3 polyunsaturated fatty acids in secondary prevention after myocardial infarction.
    Lamotte M; Annemans L; Kawalec P; Zoellner Y
    Pharmacoeconomics; 2006; 24(8):783-95. PubMed ID: 16898848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Omega-3 fatty acids in secondary prevention after myocardial infarct].
    Rupp H
    Clin Res Cardiol; 2006; 95 Suppl 6():VI12-6. PubMed ID: 17013579
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Omega-3 polyunsaturated fatty acids and cardiovascular diseases].
    Marchioli R
    Minerva Cardioangiol; 2003 Oct; 51(5):561-76. PubMed ID: 14551524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Do fish oils or vitamin E reduce morbidity and mortality after myocardial infarction?
    Rand PJ; Schooff M
    J Fam Pract; 1999 Nov; 48(11):847-8. PubMed ID: 10907618
    [No Abstract]   [Full Text] [Related]  

  • 20. Omega-3 polyunsatured fatty acids role in postmyocardial infarction therapy.
    Imazio M; Forno D; Quaglia C; Trinchero R
    Panminerva Med; 2003 Jun; 45(2):99-107. PubMed ID: 12855934
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.